SAN FRANCISCO -- Operators had a favorable early experience using the Tendyne transcatheter mitral valve replacement (TMVR) system for severe mitral regurgitation (MR) and mitral annular calcification ...

For patients with significant mitral regurgitation (MR) who are unsuitable for surgical intervention or transcatheter edge-to-edge repair (TEER), transcatheter mitral valve replacement (TMVR) appears ...

NeoChord, Inc. (“NeoChord”) announced on October 4, 2021 that it successfully completed a first-in-human procedure with the NeXuS Transcatheter Mitral Chordal Repair (TMVr) device NeoChord is ...

PHOENIX, AZ—Symptomatic patients with moderate-to-severe mitral regurgitation (MR) ineligible for surgery fare quite well with transapical (TA) transcatheter mitral valve replacement (TMVR), with more ...

Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making it the first minimally invasive, catheter-based treatment that uses a ...

Most devicemakers aiming to provide a treatment for mitral regurgitation—see Abbott, Medtronic, InnovHeart and more—are doing so by developing implants that are placed directly within a faulty mitral ...

BALTIMORE, MD — Transcatheter mitral-valve repair (TMVR) is to be covered under Medicare for the treatment of significant symptomatic degenerative mitral regurgitation (MR), the Centers for Medicare & ...

Please provide your email address to receive an email when new articles are posted on . At 30 days, a group of 15 patients who underwent transfemoral transcatheter mitral valve replacement for ...

MUNSTER — Cardiovascular specialists of Community Healthcare System successfully have performed the first transcatheter mitral valve replacement procedure in Northwest Indiana, the hospital system ...

TRINITY is a global prospective, multicenter, single-arm clinical trial, which primarily aims to evaluate the safety and efficacy of LuX-Valve Plus in application on patients with severe tricuspid ...